HIV-DNA vaccination following transfer of a large number of activated T cells enhances immunoresponses against HIV-1.
Hamajima
K
K
Department of Bacteriology, Yokohama City University School of Medicine, Yokohama, Japan.
Xin
K Q
KQ
Fukushima
J
J
Yang
J
J
Honsho
A
A
Nakazawa
M
M
Yanoma
S
S
Okuda
K
K
D016915:AIDS Vaccines / Q000008:administration & dosage / Q000276:immunology*; D000818:Animals; D002478:Cells, Cultured; D015483:HIV Antibodies / Q000096:biosynthesis* / Q000097:blood; D015658:HIV Infections / Q000517:prevention & control; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology / Q000637:transplantation*; D014611:Vaccination; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000276:immunology*
D016915:AIDS Vaccines; D015483:HIV Antibodies; D007071:Immunoglobulin A, Secretory; D019444:Vaccines, DNA